Location History:
- Taejon, KR (2012)
- Daejeon, KR (2013)
Company Filing History:
Years Active: 2012-2013
Title: Innovations by Inventor Mee Sook Oh from Daejeon, KR
Introduction
Mee Sook Oh is an accomplished inventor based in Daejeon, South Korea. He has made significant contributions to the field of biomedicine through his innovative work on humanized antibodies and monoclonal antibodies. With a total of two patents to his name, his research focuses on creating specialized antibodies that have important applications in healthcare.
Latest Patents
Mee Sook Oh's latest patents include two notable inventions. The first is titled "Humanized antibody and process for preparing same," which details a process for producing a humanized antibody. This process involves selecting a specificity determining residue (SDR) from the complementarity determining region (CDR) of murine monoclonal antibody heavy chain and light chain variable regions, followed by grafting the SDR to human antibody variable regions. The second patent is for a "Monoclonal antibody specific to anthrax toxin." This patent describes an antibody with a high affinity for anthrax toxin and potent neutralizing activity, along with a composition for neutralizing the toxin and a kit for detecting anthrax toxin.
Career Highlights
Mee Sook Oh works at Aprogen Inc., where he continues to push the boundaries of immunology with his research and innovative solutions. His work has the potential to significantly impact treatments for various diseases, especially those related to toxin exposure. He has demonstrated great expertise in the field, combining scientific knowledge with practical applications.
Collaborations
In his professional endeavors, Mee Sook Oh collaborates closely with esteemed colleagues, including Hyo Jeong Hong and Cheol-Young Maeng. Together, they contribute to groundbreaking research and the development of new therapeutic solutions in the biotechnology sector.
Conclusion
Mee Sook Oh stands out as a prominent inventor in the realm of antibody research. His patents reflect a commitment to advancing medical science and enhancing the efficacy of treatments for serious health threats. With ongoing collaborations and a focus on innovation, he is poised to make lasting contributions to biotechnology and public health.